Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2005
02/17/2005WO2005015238A2 Platinum complexes for differential mass labelling
02/17/2005WO2005015237A1 Ophthalmic sensor
02/17/2005WO2005015236A2 A method for predicting the progression of adenocarcinoma
02/17/2005WO2005015235A1 Method for detecting low levels of a fusion protein
02/17/2005WO2005015234A1 Use of protein sahh as a marker for colorectal cancer
02/17/2005WO2005015233A1 Use of protein spermidine synthase (spee) as a marker for colorectal cancer
02/17/2005WO2005015232A1 Use of protein proteasmose activator subunit 3 (pse3) as a marker for colorectal cancer
02/17/2005WO2005015231A1 Use of protein spermidine synthase (spee) as a marker for colorectal cancer
02/17/2005WO2005015230A1 Use of protein psa3 as a marker for colorectal cancer
02/17/2005WO2005015229A1 Use of protein psa3 as a marker for colorectal cancer
02/17/2005WO2005015228A1 Use of protein proteasome activator subunit 3 (pse3) as a marker for colorectal cancer
02/17/2005WO2005015227A1 Use of protein t- plastin (plst) as a marker for colorectal cancer
02/17/2005WO2005015226A1 Use of protein t-plastin (plst) as a marker for colorectal cancer
02/17/2005WO2005015225A1 Use of the far upstream element (fuse) binding protein (fubp) as a marker for colorectal cancer
02/17/2005WO2005015224A1 Use of protein acidic ribosomal protein po (rla-0) as a marker for colorectal cancer
02/17/2005WO2005015223A1 Use of protein acidic ribosomal protein p0 (rla-0) as a marker for colorectal cancer
02/17/2005WO2005015222A1 Use of the far upstream element (fuse) binding protein (fubp) as a marker for colorectal cancer
02/17/2005WO2005015221A1 Use of protein sahh as a marker for colorectal cancer
02/17/2005WO2005015220A1 Use of protein crabp-i as a marker for breast cancer
02/17/2005WO2005015219A1 Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as marker for colorectal cancer
02/17/2005WO2005015218A1 Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as a marker for colorectal cancer
02/17/2005WO2005015217A1 Tool for measuring object to be measured, measuring device, and measuring method
02/17/2005WO2005015216A1 Process for preparing coated magnetic particles
02/17/2005WO2005015215A1 Novel chemiluminescent compounds and their use
02/17/2005WO2005015214A1 Novel chemiluminescent compounds and their use
02/17/2005WO2005015213A1 Fluorescent magnetic nanoparticles and process of preparation
02/17/2005WO2005015212A1 Reagent for producing a protein chip
02/17/2005WO2005015211A1 Solid support for immobilizing nucleic acid molecule
02/17/2005WO2005015210A1 Motion induced electrical field stimulation background
02/17/2005WO2005015209A2 Methods and systems for the annotation of biomolecule patterns in chromatography/mass-spectrometry analysis
02/17/2005WO2005015208A1 Method for testing ghrelin release
02/17/2005WO2005015207A2 Method and diagnostic tests based on flow cytometric analysis of antigen-specific t lymphocytes
02/17/2005WO2005015206A2 Secreted polypeptide species associated with cardiovascular disorders
02/17/2005WO2005015205A2 Use of sap
02/17/2005WO2005015204A2 Diagnostics and therapeutics for diseases associated with organic anion transporter ust3 like 3 (ust3 like 3)
02/17/2005WO2005015203A2 Diagnostics and therapeutics for diseases associated with g protein-coupled opioid receptor mu 1 (oprm1)
02/17/2005WO2005015202A1 Method and device for measuring the strip mass and/or variations in the strip mass of a running fiber assembly and spinning preparation machine equipped with a measuring device
02/17/2005WO2005015200A1 Simple diagnosis of disorder with sera and tailor made treatment
02/17/2005WO2005015191A1 Gas sensor and gas detecting method
02/17/2005WO2005015190A1 Method and arrangement for detecting substances by means of regulation of an electrical resistance of a sensor
02/17/2005WO2005015180A1 Real-time on-line sensing and control of emulsions in formation fluids
02/17/2005WO2005015177A1 Apparatus for mesuruing moisture content of cartilate using near infrared moisture meter and measuring method
02/17/2005WO2005015176A1 Gas detector
02/17/2005WO2005015175A1 A method of compensating for a measuring error and an electronic arrangement to this end
02/17/2005WO2005015169A1 Viscosity sensor assembly
02/17/2005WO2005015161A2 Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation
02/17/2005WO2005015159A2 Methods for modulating a drug-related effect or behavior
02/17/2005WO2005015158A2 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
02/17/2005WO2005015156A2 Molecular detector
02/17/2005WO2005014977A1 Apparatus and method for measuring concentrations of scale-forming ions
02/17/2005WO2005014857A2 Nucleic acid arrays for detecting multiple strains of a non-viral species
02/17/2005WO2005014856A1 Sensitivity test to predict efficacy of anti-cancer therapies
02/17/2005WO2005014855A1 Method for detecting contaminants in pharmaceutical anthracycline products
02/17/2005WO2005014852A1 Microarrays of immobilized biomolecules, production thereof, and use thereof
02/17/2005WO2005014850A2 Systems and methods for analyzing nucleic acid sequences
02/17/2005WO2005014848A2 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES
02/17/2005WO2005014847A2 Reagents, methods and kits for detecting feed enzymes
02/17/2005WO2005014818A1 Gene overexpressed in cancer
02/17/2005WO2005014809A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide
02/17/2005WO2005014797A2 P16 mediated regulation of nmda receptors
02/17/2005WO2005014795A2 Osteoarthritis biomarkers and uses thereof
02/17/2005WO2005014793A2 Primary rat hepatocyte toxicity modeling
02/17/2005WO2005014788A2 Tssk4: a human testis specific serine/threonine kinase
02/17/2005WO2005014781A2 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
02/17/2005WO2005014695A1 Arrays of immobilized biomolecules on hydrogel-forming surfaces, production thereof, and use thereof
02/17/2005WO2005014645A2 Pedf-r receptor and uses
02/17/2005WO2005014636A1 Genetically encoded bioindicators of calcium-ions
02/17/2005WO2005014635A2 Secreted polypeptide species reduced in cardiovascular disorders
02/17/2005WO2005014633A1 Fluorescent protein
02/17/2005WO2005014630A2 Streptococcus pneumoniae knockout mutants
02/17/2005WO2005014627A1 Recombinant dengue multi epitope proteins as diagnostic intermediates
02/17/2005WO2005014618A2 Bispecific antibodies for inducing apoptosis of tumor and diseased cells
02/17/2005WO2005014616A2 Complexes of gpcr142 and relaxin3 or insl5, and their production and use
02/17/2005WO2005014581A2 Lanthanide complexes preparation and uses thereof
02/17/2005WO2005014173A1 Device and methods for collection of biological fluidsample and treatment of selected components
02/17/2005WO2005014034A1 Stabilized formulation of parathyroid hormone
02/17/2005WO2005014029A2 Use of dg008, dg065, dg210 or dg 239 secreted protein products for preventing and treating pancreatic diseases, obesity or metabolic syndrome
02/17/2005WO2005013950A2 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
02/17/2005WO2005013947A2 Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer
02/17/2005WO2005013912A2 Anti-fcrn antibodies for treatment of auto/allo immune conditions
02/17/2005WO2005013899A2 Compositions and methods for the therapy and diagnosis of lung cancer
02/17/2005WO2005013890A2 Function and regulation of angiopoietin-3/angiopoietin-4
02/17/2005WO2005013889A2 Truncated fragments of alpha-synuclein in lewy body disease
02/17/2005WO2005013849A2 Methods for managing animal processing operations
02/17/2005WO2005013804A2 ErbB RECEPTOR METHODS AND KITS FOR MONITORING CHEMOTHERAPY RESISTANCE
02/17/2005WO2005013682A2 Animal model for the analysis of tumor metastasis
02/17/2005WO2005013666A2 Novel translocation assay
02/17/2005WO2005001470A3 Gas chromatography-olfaction analysis device and method
02/17/2005WO2004113896A3 System and method for analysis of a biological fluid by the use electrical means
02/17/2005WO2004107958A3 Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
02/17/2005WO2004097412A3 Detection of analytes in fecal samples
02/17/2005WO2004094986A3 System and method for electrochemical detection of biological compounds
02/17/2005WO2004091558A3 Compounds for stimulating and for inhibiting melanin formation, and methods for screening these compounds
02/17/2005WO2004090536B1 Method of analysing the cytoskeletal protein of cells
02/17/2005WO2004087044A3 Drug target
02/17/2005WO2004083398A3 Therapeutic uses of hmgn1 and hmgn2
02/17/2005WO2004073645A3 Inhibition of olfatory neurosensory function of treat eating disorders and obesity
02/17/2005WO2004070386A3 Novel screening method
02/17/2005WO2004059589A3 Non-specific sensor array detectors
02/17/2005WO2004048911A3 System and method for tracking environmental emission reductions
1 ... 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 ... 3937